Search Results (538)

Exosomes are nanoscale extracellular vesicles (EVs) that carry biomolecular signatures reflective of their parent cells, making them powerful tools for non-invasive diagnostics and therapeutic monitoring. Despite their potential, clinical application is hindered by challenges such as low abundance, heterogeneity, and the complexity of biological samples. To address these limitations, plasmonic biosensing technologies—particularly propagating surface plasmon resonance (PSPR), localized surface plasmon resonance (LSPR), and surface-enhanced Raman scattering (SERS)—have been developed to enable label-free, highly sensitive, and multiplexed detection at the single-vesicle level. This review outlines recent advancements in nanoplasmonic platforms for exosome detection and profiling, emphasizing innovations in nanostructure engineering, microfluidic integration, and signal enhancement. Representative applications in oncology, neurology, and immunology are discussed, along with the increasingly critical role of artificial intelligence (AI) in spectral interpretation and diagnostic classification. Key technical and translational challenges—such as assay standardization, substrate reproducibility, and clinical validation—are also addressed. Overall, this review highlights the synergy between exosome biology and plasmonic nanotechnology, offering a path toward real-time, precision diagnostics via sub-femtomolar detection of exosomal miRNAs through next-generation biosensing strategies. Full article

Magnetotactic bacteria (MTB), a unique group of Gram-negative prokaryotes, have the remarkable ability to biomineralize magnetic nanoparticles (MNPs) intracellularly, making them promising candidates for various biomedical applications such as biosensors, drug delivery, imaging contrast agents, and cancer-targeted therapies. To fully exploit the potential of MTB, a precise understanding of the structural, surface, and functional properties of these biologically produced nanoparticles is required. Given these concerns, this review provides a focused synthesis of the most widely used microscopic and spectroscopic methods applied in the characterization of MTB and their associated MNPs, covering the latest research from January 2022 to May 2025. Specifically, various optical microscopy techniques (e.g., transmission electron microscopy (TEM), scanning electron microscopy (SEM), and atomic force microscopy (AFM)) and spectroscopic approaches (e.g., localized surface plasmon resonance (LSPR), surface-enhanced Raman scattering (SERS), and X-ray photoelectron spectroscopy (XPS)) relevant to ultrasensitive MTB biosensor development are herein discussed and compared in term of their advantages and disadvantages. Overall, the novelty of this work lies in its clarity and structure, aiming to consolidate and simplify access to the most current and effective characterization techniques. Furthermore, several gaps in the characterization methods of MTB were identified, and new directions of methods that can be integrated into the study, analysis, and characterization of these bacteria are suggested in exhaustive manner. Finally, to the authors’ knowledge, this is the first comprehensive overview of characterization techniques that could serve as a practical resource for both younger and more experienced researchers seeking to optimize the use of MTB in the development of advanced biosensing systems and other biomedical tools. Full article

Indoleamine 2,3-dioxygenase 1 (IDO-1) and interferon-gamma (IFN-γ) are proteins that play a significant role in inflammatory conditions and tumor development. The detection of IDO1 and IFN-γ is crucial for understanding their interplay in immune responses. This study introduced a novel method for the simultaneous quantitative determination of IDO-1 and IFN-γ in different biological samples/materials. The method is based on an optical biosensor, with surface plasmon resonance detection carried out by the imaging version of the sensor (SPRi). Biotinylated antibodies immobilized on the surfaces of the linker and carboxymethylated dextran served as the recognition elements for the developed biosensor. Relevant studies were conducted to optimize the activities of the biosensor by employing appropriate reagent concentrations. Validation was performed for each protein separately; low detection and quantification limits were obtained (for IDO-1 LOD = 0.27 ng/mL, LOQ = 0.81 ng/mL; for IFN-γ LOD = 1.76 pg/mL and LOQ = 5.29 pg/mL). The sensor operating ranges were 0.001–10 ng/mL for IDO-1 and 0.1–1000 pg/mL for IFN-γ. The constructed biosensor demonstrated its sensitivity and precision when the appropriate analytical parameters were determined, based on the proposed method. It can also selectively capture IDO-1 and IFN-γ from a large sample matrix. The biosensor efficiency was confirmed by the determination of IDO-1 and IFN-γ in simultaneous measurements of the plasma and urine samples of patients diagnosed with bladder cancer and the control group. The outcomes were compared to those obtained using a certified ELISA test, demonstrating convergence between the two methodologies. The preliminary findings demonstrate the biosensor’s efficacy and suitability for comprehensive analyses of the examined biological samples. Full article

The integration of two-dimensional graphene with gold nanostructures has significantly advanced surface plasmon resonance (SPR)-based optical biosensors, due to graphene’s exceptional optical, electronic, and surface properties. This review examines recent developments in graphene-based hybrid nanomaterials designed to enhance SPR sensor performance. The synergistic combination of graphene and other functional materials enables superior plasmonic sensitivity, improves biomolecular interaction, and enhances signal transduction. Key focus areas include the fundamental principle of graphene-enhanced SPR, the functional advantages of graphene hybrid platforms, and their recent applications in detecting biomolecules, disease biomarkers, and pathogens. Finally, current limitations and potential future perspectives are discussed, highlighting the transformative potential of these hybrid nanomaterials in next-generation optical biosensing Full article

Diagnosing Alzheimer’s disease (AD) remains a significant challenge due to its multifactorial nature and the limitations of traditional diagnostic methods, such as clinical assessments and neuroimaging, which often lack the specificity and sensitivity required for early detection. The urgent need for innovative diagnostic tools is further underscored by the potential of early intervention to improve treatment outcomes and slow disease progression. Recent advancements in biosensing technologies offer promising solutions for precise and non-invasive AD detection. Electrochemical and optical biosensors, in particular, provide high sensitivity, specificity, and real-time detection capabilities, making them valuable for identifying key biomarkers, including amyloid-β (Aβ) peptides and tau proteins. Additionally, integrating these biosensors with nanomaterials enhances their performance, stability, and detection limits, enabling improved diagnostic accuracy. Beyond nanomaterial-based sensors, emerging innovations in microfluidics, surface plasmon resonance (SPR), and artificial intelligence-assisted biosensing further contribute to the development of next-generation AD diagnostics. This review provides a comprehensive analysis of the latest advancements in biosensing technologies for AD, highlighting their mechanisms, advantages, and future perspectives in detecting biomarkers from biological fluids. Full article

Accurate detection of biomolecular interactions is essential in many areas, from the detection of the presence of biomarkers in the clinic to the development of therapeutic drugs and biologics in biopharma to the understanding of various biological processes in basic research. Traditional endpoint approaches can suffer from false-negative results for biomolecular interactions with fast kinetics. By contrast, real-time detection techniques like surface plasmon resonance (SPR) monitor interactions as they form and disassemble, reducing the risk of false-negative results. By leveraging cell-free expressed proteins captured on either glass or SPR biosensors and using two different commercial antibodies with variable off-rates that both target HaloTag antigens as a model, we compare and contrast results from a fluorescence endpoint assay versus real-time sensor-integrated proteome on chip (SPOC^®) SPR-based detection. In this study, we illustrate the limitations of the representative immunofluorescent endpoint assay when investigating transient interactions characterized by fast dissociation rates. We highlight the importance of choosing reagents well suited to the selected assay, as well as the importance of considering binding kinetics and protein ligand conformational states when interpreting results from binding assays, especially for applications as critical as the off-target screening of therapeutics. Full article

Two-dimensional transition metal carbides/nitrides (MXenes) have shown potential in biosensors, cancer theranostics, microbiology, electromagnetic interference shielding, photothermal conversion, and thermal energy storage due to their unique electronic structure, ability to absorb a wide range of light, and tunable surface chemistry. In spite of the growing interest in MXenes, there are relatively few studies on their applications in phase-change materials for enhancing thermal conductivity and weak photo-responsiveness between 0 °C and 150 °C. Thus, this study aims to provide a current overview of recent developments, to examine how MXenes are made, and to outline the combined effects of different processes that can convert light into heat. This study illustrates the mechanisms that include enhanced broadband photon harvesting through localized surface plasmon resonance, electron–phonon coupling-mediated nonradiative relaxation, and interlayer phonon transport that optimizes thermal diffusion pathways. This study emphasizes that MXene-engineered 3D thermal networks can greatly improve energy storage and heat conversion, solving important problems with phase-change materials (PCMs), like poor heat conductivity and low responsiveness to light. This study also highlights the real-world issues of making MXene-based materials on a large scale, and suggests future research directions for using them in smart thermal management systems and solar thermal grid technologies. Full article

The rapid and precise identification of multiple pathogens is critical for ensuring food safety, controlling epidemics, diagnosing diseases, and monitoring the environment. However, traditional detection methods are hindered by complex workflows, the need for skilled operators, and reliance on sophisticated equipment, making them unsuitable for rapid, on-site testing. Optical biosensors, known for their rapid analysis, portability, high sensitivity, and multiplexing capabilities, offer a promising solution for simultaneous multi-pathogenic identification. This paper explores recent advancements in the utilization of optical biosensors for multiple pathogenic detection. First, it provides an overview of key sensing principles, focusing on colorimetric, fluorescence-based, surface-enhanced Raman scattering (SERS), and surface plasmon resonance (SPR) techniques, as well as their applications in pathogenic detection. Then, the research progress and practical applications of optical biosensors for multiplex pathogenic detection are discussed in detail from three perspectives: microfluidic devices, nucleic acid amplification technology (NAAT), and nanomaterials. Finally, the challenges presented by optical biosensing technologies in multi-pathogen detection are discussed, along with future prospects and potential innovations in the field. Full article

The growing demand for low-cost biosensors has stimulated the study of new technologies and materials like molybdenum disulfide (MoS₂). Due to its electroconductive nature and high surface-to-volume ratio, it allows for the ultra-sensitive detection of biomarkers. The crystal structure of MoS₂ provides it with a unique micrometer thickness, making it appropriate for biosensing in healthcare, environmental monitoring, and food safety. As compared to traditional materials, MoS₂ can work without labels (through field-effect transduction or plasmonic shifts) while maintaining biocompatibility and low-cost fabrication, which fill significant voids in the early diagnosis of diseases. This paper provides an overview of the recent advancements in MoS₂-based biosensors, which are primarily focused on the field-effect transistors and surface plasmon resonance techniques and fabrication methods for MoS₂-based biosensors like mechanical exfoliation, liquid-phase exfoliation, physical vapor deposition, chemical vapor deposition, and chemical exfoliation, applications in various industries, and their characterization techniques to evaluate the quality and functionality of MoS₂ nanosheets in biosensors. While certain challenges remain like improving conductivity and scalability, MoS₂-based biosensors serve as a powerful tool for the precise and reliable detection of biomarkers in environmental, food, and healthcare industries. Full article

Osteopontin (OPN) is a protein that plays many essential functions in the human body. It is present in most tissues and body fluids. OPN, among other things, participates in wound healing, the formation and remodeling of bone, immune response, inflammation, angiogenesis, and tumor formation. A new analytical method, based on SPRi (surface plasmon resonance imaging) biosensors, has been developed to determine osteopontin in biological fluids. OPN was captured from a solution by an immobilized antibody (mouse or rabbit), a bioreceptor in the SPRi sensor. A separate validation process was carried out for each antibody used. The LOD and LOQ values obtained for the biosensor with mouse antibody were 0.014 ng mL⁻¹ and 0.043 ng mL⁻¹, respectively, and those obtained for the biosensor with rabbit antibody were 0.018 ng mL⁻¹ and 0.055 ng mL⁻¹, respectively. The response ranges of both biosensors were in a similar range: 0.05–1.00 ng mL⁻¹. OPN was determined in blood plasma to demonstrate the sensor potential, showing good agreement with the data obtained using an ELISA test and reported in the literature. The presented method is characterized by ease and speed of measurement, and the process does not require special preparation of samples. Full article

SPR biosensors operate on the principle of evanescent wave propagation at metal–dielectric interfaces in total internal reflection conditions, with consequent photonic energy attenuation. This plasmonic excitation occurs in specific conditions of incident light wavelength, angle, and the dielectric refractive index. This principle has been the basis for SPR-based biosensor setups wherein mass/concentration-induced changes in the refractive indices of dielectric media reflect as plasmonic resonance condition changes quantitatively reported as arbitrary response units. SPR biosensors operating on this conceptual framework have been designed to study biomolecular interactions with real-time readout and in label-free setups, providing key kinetic characterization that has been valuable in various applications. SPR biosensors often feature antibodies as target affinity probes. Notably, the operational challenges encountered with antibodies have led to the development of aptamers—oligonucleotide biomolecules rationally designed to adopt tertiary structures, enabling high affinity and specific binding to a wide range of targets. Aptamers have been extensively adopted in SPR biosensor setups with promising clinical and industrial prospects. In this paper, we explore the growing literature on SPR setups featuring aptamers, specifically providing expert commentary on the current state and future implications of these SPR aptasensors for drug discovery as well as disease diagnosis and monitoring. Full article

The early and accurate detection of cancer remains a critical challenge in biomedical diagnostics. In this work, we propose and investigate a novel surface plasmon resonance (SPR) biosensor platform based on a multilayer configuration incorporating copper (Cu), silicon nitride (Si₃N₄), and molybdenum disulfide (MoS₂) for the optical detection of various cancer types. Four distinct sensor architectures (Sys₁–Sys₄) were optimized through the systematic tuning of Cu thickness, Si₃N₄ dielectric layer thickness, and the number of MoS₂ monolayers to enhance sensitivity, angular shift, and spectral sharpness. The optimized systems were evaluated using refractive index data corresponding to six cancer types (skin, cervical, blood, adrenal, breast T1, and breast T2), with performance metrics including sensitivity, detection accuracy, quality factor, figure of merit, limit of detection, and comprehensive sensitivity factor. Among the configurations, Sys₃ (BK7–Cu–Si₃N₄–MoS₂) demonstrated the highest sensitivity, reaching 254.64 °/RIU for adrenal cancer, while maintaining a low detection limit and competitive figures of merit. Comparative analysis revealed that the MoS₂-based designs, particularly Sys₃, outperform conventional noble-metal architectures in terms of sensitivity while using earth-abundant, scalable materials. These results confirm the potential of Cu/Si₃N₄/MoS₂-based SPR biosensors as practical and effective tools for label-free cancer diagnosis across multiple malignancy types. Full article

Background: Endometriosis is a common gynecological disease linked to significant diagnostic challenges. Cadherin 12 (CDH12), as a member of adhesion molecules, is supposed to be involved in the pathogenesis of this disease and therefore can be a potential biomarker candidate. Methods: In this study, we analyzed the concentration of CDH12 in plasma and peritoneal fluid samples collected from women with endometriosis and controls, using surface plasmon resonance imaging (SPRi). We collected plasma samples from 96 women and peritoneal fluid from 73 women after laparoscopy due to symptoms/ultrasound findings suggestive of endometriosis. The diagnosis was confirmed histologically. In the collected samples, we measured the concentrations of CDH12 using a novel technique utilizing an SPRi biosensor. Results: We found that peritoneal fluid CDH12 concentrations were lower in women with infertility compared to fertile women. However, we observed no differences in concentration of CDH12 between endometriosis and control groups in both plasma and peritoneal fluid. Additionally, in a study group of patients with confirmed endometriosis, we observed a significant positive correlation of CDH12 concentrations with patients’ age. Overall, plasma concentrations of CDH12 were significantly greater as compared to levels found in peritoneal fluid. Conclusion: Cadherin 12 has not been confirmed to show direct diagnostic potential for endometriosis using the SPRi method, at least in our cohort of patients. Full article

Silver nanoparticles (AgNPs) have attracted tremendous attention in recent years due to their unique physicochemical properties, including pronounced surface plasmon resonance, tunable size, and amenability to functionalization. These attributes underpin the growing interest in AgNPs as SMART nanocarriers for targeted drug delivery and as active components in biosensing platforms. In this work, we discuss various synthesis strategies for AgNPs—ranging from conventional chemical methods to green approaches—and highlight their subsequent functionalization with anticancer drugs, notably doxorubicin (DOX). We also examine the potential of AgNPs in biosensor applications, emphasizing electrochemical and optical detection modalities capable of monitoring drug release, oxidative stress, and relevant biomarkers. Our experimental data support the conclusion that AgNPs can effectively improve therapeutic efficacy by exploiting tumor-specific conditions (e.g., lower pH) while also enhancing biosensor sensitivity via surface plasmon resonance and electrochemical signal amplification. We provide a thorough discussion of the results, including mechanistic aspects of reactive oxygen species (ROS) generation, drug release kinetics, and sensor performance metrics. Overall, AgNP-based nanocarriers emerge as a powerful platform to address current challenges in precision oncology and medical diagnostics. Full article

Two-dimensional nanomaterials (2DNMs) exhibit significant potential for the development of functional and specifically targeted biosensors, owing to their unique planar nanosheet structures and distinct physical and chemical properties. Biomodification and biomimetic synthesis offer green and mild approaches for the fabrication of multifunctional nanohybrids with enhanced catalytic, fluorescent, electronic, and optical properties, thereby expanding their utility in constructing high-performance biosensors. In this review, we present recent advances in the synthesis of 2DNM-based nanohybrids via both biomodification and biomimetic strategies for biosensor applications. We discuss covalent and non-covalent biomodification methods involving various biomolecules, including peptides, proteins, DNA/RNA, enzymes, biopolymers, and bioactive polysaccharides. The engineering of biomolecule–nanomaterial interfaces for the creation of biomodified 2DNM-based nanohybrids is also explored. Furthermore, we summarize the biomimetic synthesis of 2DNM-based bio–nanohybrids through pathways such as bio-templating, biomolecule-directed self-assembly, biomineralization, and biomimetic functional integration. The potential applications of these nanohybrids in diverse biosensing platforms—including colorimetric, surface plasmon resonance, electrochemical, fluorescence, photoelectrochemical, and integrated multimodal biosensors—are introduced and discussed. Finally, we analyze the opportunities and challenges associated with this rapidly developing field. We believe this comprehensive review will provide valuable insights into the biofunctionalization of 2DNMs and guide the rational design of advanced biosensors for diagnostic applications. Full article